LRRC8C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.808300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.876000E-02
Normal-vs-Stage2
3.807900E-02
Normal-vs-Stage3
1.130190E-01
Normal-vs-Stage4
1.442200E-01
Stage1-vs-Stage2
8.914800E-01
Stage1-vs-Stage3
3.788600E-01
Stage1-vs-Stage4
9.148400E-01
Stage2-vs-Stage3
4.037500E-02
Stage2-vs-Stage4
9.940200E-01
Stage3-vs-Stage4
4.484200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.196300E-02
Normal-vs-AfricanAmerican
2.157200E-01
Normal-vs-Asian
4.756100E-03
Caucasian-vs-AfricanAmerican
5.874400E-01
Caucasian-vs-Asian
2.251200E-01
AfricanAmerican-vs-Asian
2.070000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.574300E-02
Normal-vs-Female
6.055800E-02
Male-vs-Female
8.354500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.893040E-01
Normal-vs-Age(41-60Yrs)
1.370960E-01
Normal-vs-Age(61-80Yrs)
1.307890E-02
Normal-vs-Age(81-100Yrs)
3.279500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.791600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.837400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.167420E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.657560E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.726000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.703800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.565000E-03
Normal-vs-Daily Drinker
5.963700E-04
Normal-vs-Weekly Drinker
1.936200E-03
Normal-vs-Occasional Drinker
5.614000E-02
Normal-vs-Social Drinker
2.012000E-01
Non Drinker-vs-Daily Drinker
5.378400E-01
Non Drinker-vs-Weekly Drinker
9.040600E-01
Non Drinker-vs-Occasional Drinker
3.664000E-01
Non Drinker-vs-Social Drinker
3.119400E-01
Daily Drinker-vs-Weekly Drinker
4.588800E-01
Daily Drinker-vs-Occasional Drinker
1.940420E-01
Daily Drinker-vs-Social Drinker
1.838970E-01
Weekly Drinker-vs-Occasional Drinker
4.575200E-01
Weekly Drinker-vs-Social Drinker
3.473400E-01
Occasional Drinker-vs-Social Drinker
7.044400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.058200E-01
Normal-vs-Grade 2
3.177000E-01
Normal-vs-Grade 3
4.022600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.414800E-01
Grade 1-vs-Grade 3
8.258800E-01
Grade 1-vs-Grade 4
6.058200E-01
Grade 2-vs-Grade 3
2.319600E-01
Grade 2-vs-Grade 4
3.177000E-01
Grade 3-vs-Grade 4
4.022600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.742500E-02
Normal-vs-NonDiabetic
1.474230E-02
Diabetic-vs-NonDiabetic
5.582600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.754900E-04
Normal-vs-NoPancreatitis
2.384000E-02
Pancreatitis-vs-NoPancreatitis
2.176400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.724100E-02
Normal-vs-N1
3.630400E-02
N0-vs-N1
4.377600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.244870E-03
Normal-vs-TP53-NonMutant
3.410000E-02
TP53-Mutant-vs-TP53-NonMutant
2.464200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
